Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Fixed Capital/Sales

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.500.420.480.360.36

What is the latest Fixed Capital/Sales ratio of NGL FINECHEM ?

The latest Fixed Capital/Sales ratio of NGL FINECHEM is 0.50 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.50
Mar20240.42
Mar20230.48
Mar20220.36
Mar20210.36

How is Fixed Capital/Sales of NGL FINECHEM Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.5
19.05
Mar2024 0.42
-12.50
Mar2023 0.48
33.33
Mar2022 0.36
0.00
Mar2021 0.36 -

Other Financial Ratios of NGL FINECHEM


Compare Fixed Capital/Sales ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,450.7 Cr -2.7% 4.9% 122.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,879.0 Cr 1.5% 6.9% 13.1% Stock Analytics
DIVIS LABORATORIES ₹166,620.0 Cr -0.8% 1.7% 14% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,431.0 Cr 3.2% 9% 44.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,070.0 Cr 1.1% 5% 16.4% Stock Analytics
CIPLA ₹107,051.0 Cr 0.3% -1.3% -9% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-2.7%

4.9%

122.1%

SENSEX

-5%

-9.6%

3.1%


You may also like the below Video Courses